CRDL
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
124.33M
31 days until earnings call
CRON
Price
$1.77
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
1B
24 days until earnings call
Ad is loading...

CRDL vs CRON

Header iconCRDL vs CRON Comparison
Open Charts CRDL vs CRONBanner chart's image
Cardiol Therapeutics
Price$1.01
Change-$0.00 (-0.00%)
Volume$124.72K
Capitalization124.33M
Cronos Group
Price$1.77
Change-$0.00 (-0.00%)
Volume$2.25M
Capitalization1B
CRDL vs CRON Comparison Chart
Loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDL vs. CRON commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and CRON is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (CRDL: $1.01 vs. CRON: $1.77)
Brand notoriety: CRDL and CRON are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRDL: 52% vs. CRON: 143%
Market capitalization -- CRDL: $124.33M vs. CRON: $1B
CRDL [@Pharmaceuticals: Other] is valued at $124.33M. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 5 TA indicator(s) are bullish while CRON’s TA Score has 4 bullish TA indicator(s).

  • CRDL’s TA Score: 5 bullish, 3 bearish.
  • CRON’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRDL is a better buy in the short-term than CRON.

Price Growth

CRDL (@Pharmaceuticals: Other) experienced а +12.72% price change this week, while CRON (@Pharmaceuticals: Other) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

CRDL is expected to report earnings on Aug 18, 2025.

CRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than CRDL($124M). CRON YTD gains are higher at: -12.376 vs. CRDL (-21.094). CRDL has higher annual earnings (EBITDA): -30.61M vs. CRON (-71.8M). CRON has more cash in the bank: 862M vs. CRDL (40.5M). CRDL has less debt than CRON: CRDL (181K) vs CRON (2.55M). CRON has higher revenues than CRDL: CRON (87.2M) vs CRDL (0).
CRDLCRONCRDL / CRON
Capitalization124M1.01B12%
EBITDA-30.61M-71.8M43%
Gain YTD-21.094-12.376170%
P/E RatioN/AN/A-
Revenue087.2M-
Total Cash40.5M862M5%
Total Debt181K2.55M7%
FUNDAMENTALS RATINGS
CRDL vs CRON: Fundamental Ratings
CRDL
CRON
OUTLOOK RATING
1..100
2027
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9985
PRICE GROWTH RATING
1..100
8475
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (57) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRDL (96) in the null industry. This means that CRON’s stock grew somewhat faster than CRDL’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRDL (100) in the null industry. This means that CRON’s stock grew similarly to CRDL’s over the last 12 months.

CRON's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as CRDL (99) in the null industry. This means that CRON’s stock grew similarly to CRDL’s over the last 12 months.

CRON's Price Growth Rating (75) in the Pharmaceuticals Other industry is in the same range as CRDL (84) in the null industry. This means that CRON’s stock grew similarly to CRDL’s over the last 12 months.

CRON's P/E Growth Rating (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that CRON’s stock grew somewhat faster than CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLCRON
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 6 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and CGC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
N/A
CGC - CRDL
33%
Poorly correlated
+0.85%
ACB - CRDL
32%
Poorly correlated
+2.30%
OGI - CRDL
32%
Poorly correlated
+2.88%
TLRY - CRDL
30%
Poorly correlated
-5.42%
CRON - CRDL
30%
Poorly correlated
N/A
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
N/A
TLRY - CRON
65%
Loosely correlated
-5.42%
CGC - CRON
65%
Loosely correlated
+0.85%
ACB - CRON
65%
Loosely correlated
+2.30%
OGI - CRON
62%
Loosely correlated
+2.88%
CRDL - CRON
30%
Poorly correlated
N/A
More